From Knowledge, Drug Power: Andrew Hopkins Discusses AI-Based Development on “Close to the Edge”


In a wide-ranging conversation, on Episode 14 of “Close to the Edge,” Andrew Hopkins discusses his journey from South Wales to the University of Oxford, Pfizer to the University of Dundee, and the progress made by his Oxford-based company, which he launched in 2012. Hopkins is in no doubt that artificial intelligence is poised to transform not only the chemistry of drug discovery but also many other aspects of clinical and pharmaceutical research . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge

Previous articleCOVID-19 Vaccine Gets Green Light for Children Under Five
Next articleTriple Threat: NeuroSense Targets ALS